ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
통증 관리 약물 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 847억 9,000만 달러에서 2026년에는 893억 달러에 이르고, CAGR 5.3%로 성장할 전망입니다. 지난 수년간의 성장은 만성 통증 질환의 유병률 증가, 고령 인구 증가, 통증 관리에 대한 인식 개선, 병원 및 소매 약국 네트워크의 확대, 진통제 제제의 발전 등에 기인하는 것으로 보입니다.
통증 관리 약물 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 1,088억 6,000만 달러에 이르고, CAGR은 5.1%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 통증 관리에 있어 생물학적 제제의 도입 확대, 디지털 헬스 솔루션의 통합 발전, 저침습적 시술에 대한 수요 증가, 재택치료 서비스 확대, 병용 요법의 혁신 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 개인 맞춤형 통증 관리 요법, 원격 의료 및 원격 통증 모니터링, 새로운 진통제 제제, 저침습적 통증 완화 기술, 병용 요법 접근법 등을 들 수 있습니다.
고령화 사회의 진전은 향후 통증 관리 의약품 시장의 성장을 견인할 것으로 예측됩니다. 65세 이상 노인은 관절염, 암, 신경질환, 기타 노화 관련 질환의 완화를 위해 통증 관리 약물을 필요로 하는 경우가 많습니다. 따라서 고령자 증가에 따라 통증관리 의약품에 대한 수요도 확대될 것으로 예측됩니다. 예를 들어, 2025년 11월 프랑스에 본부를 둔 정부 간 경제협력개발기구(OECD)는 지난 50년 동안 OECD 회원국의 65세 이상 인구 비율이 평균 두 배로 증가하여 2023년 18.5%에서 증가했다고 보고했습니다. 따라서 노인 인구 증가는 통증 관리 의약품 시장 확대를 견인하는 중요한 요인으로 작용하고 있습니다.
통증 관리 의약품 시장의 주요 기업들은 급성 또는 만성 통증으로 고통받는 환자들의 요구를 충족시키기 위해 신약 개발 및 FDA 승인 획득에 주력하고 있습니다. FDA 승인은 미국 식품의약국(FDA)이 의료 제품에 대해 미국 내 유통에 필요한 안전성 및 유효성 기준을 충족했음을 나타내는 규제 승인입니다. 예를 들어, 2023년 10월 벨기에에 본사를 둔 제약회사 Hyloris Pharmaceuticals는 Maxigesic IV의 미국 FDA 승인을 획득했습니다. 맥시제식 IV는 20년 만에 FDA가 승인한 최초의 비오피오이드계 진통제입니다. 파라세타몰과 이부프로펜을 배합한 비오피오이드 계열의 정맥 내 진통제로, 이중 작용기전을 통해 통증 완화를 실현합니다. 맥시제식 IV의 승인은 통증 관리 의약품 시장에서 중요한 이정표가 될 것이며, 수술 후 통증 완화를 위한 새로운 비오피오이드 계열의 선택지를 제공할 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
A pain management drug is a medication that alleviates pain. These drugs work by producing analgesia through various actions in the nervous system, such as inhibiting neurotransmitter release from primary afferent terminals in the spinal cord and activating descending inhibitory controls in the midbrain.
The primary classes of pain management drugs include non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics. NSAIDs are a type of nonsteroidal anti-inflammatory drug used to reduce high fever, decrease inflammation, and relieve discomfort. These drugs are indicated for a range of conditions, including arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraines, fibromyalgia, muscle sprains/strains, bone fractures, and more. They are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
Tariffs have influenced the pain management drugs market by affecting the cost and availability of imported active pharmaceutical ingredients (APIs) and specialized drug formulations. The resulting price fluctuations impact hospital pharmacies and retail distribution channels, particularly in North America and Europe. Segments such as opioids and biologics are most affected due to high import dependency. Positive impacts include encouraging local manufacturing, boosting domestic production capabilities, and driving innovation in cost-effective pain management solutions.
The pain management drugs market research report is one of a series of new reports from The Business Research Company that provides pain management drugs market statistics, including pain management drugs industry global market size, regional shares, competitors with a pain management drugs market share, detailed pain management drugs market segments, market trends and opportunities, and any further data you may need to thrive in the pain management drugs industry. This pain management drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pain management drugs market size has grown strongly in recent years. It will grow from $84.79 billion in 2025 to $89.3 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, increasing geriatric population, growing awareness about pain management, expansion of hospital and retail pharmacy networks, advancements in analgesic drug formulations.
The pain management drugs market size is expected to see strong growth in the next few years. It will grow to $108.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rising adoption of biologics for pain management, increasing integration of digital health solutions, growing demand for minimally invasive procedures, expansion of home healthcare services, innovation in combination therapies. Major trends in the forecast period include personalized pain management therapies, telemedicine & remote pain monitoring, novel analgesic drug formulations, minimally invasive pain relief techniques, combination therapy approaches.
The increasing geriatric population is expected to drive the growth of the pain management drugs market in the future. The geriatric population, defined as individuals aged 65 and older, often requires pain management medications to alleviate conditions like arthritis, cancer, neurological disorders, and other age-related ailments. As such, the rising number of elderly individuals is expected to boost the demand for pain management drugs. For example, in November 2025, the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental economic organization, reported that, over the past 50 years, the share of the population aged 65 and older has doubled on average across OECD countries, increasing from 18.5% in 2023. Consequently, the growth of the geriatric population is a key factor driving the expansion of the pain management drugs market.
Leading companies in the pain management drugs market are focused on developing new drugs and obtaining FDA approval to meet the needs of patients dealing with acute or chronic pain. FDA approval is the regulatory endorsement granted by the U.S. Food and Drug Administration, indicating that a medical product meets the necessary safety and efficacy standards for distribution in the U.S. For instance, in October 2023, Hyloris Pharmaceuticals, a Belgium-based pharmaceutical company, received U.S. FDA approval for Maxigesic IV. Maxigesic IV is the first non-opioid painkiller approved by the FDA in over 20 years. This non-opioid intravenous painkiller combines paracetamol and ibuprofen to provide a dual-action mechanism for pain relief. The approval of Maxigesic IV marks a significant milestone in the pain management drugs market, offering a new non-opioid option for post-operative pain relief.
In May 2025, Eli Lilly, a U.S.-based pharmaceutical company specializing in multiple therapeutic areas, including oncology, diabetes, and immunology, acquired SiteOne Therapeutics for an undisclosed amount. Through this acquisition, Eli Lilly aims to strengthen its pain management portfolio by advancing non-opioid, innovative therapies for chronic pain. SiteOne Therapeutics, a U.S.-based biotechnology company, is developing novel non-opioid pain treatments, including STC 004, a sodium-channel inhibitor for chronic pain.
Major companies operating in the pain management drugs market are Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bausch Health Companies Inc., Sanofi, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Daiichi Sankyo Company Limited, Grunenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.
North America was the largest region in the pain management drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pain management drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pain management drug market consists of sales of acetaminophen, anti-seizure medications, steroids, muscle relaxers, and other related drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pain Management Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pain management drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pain management drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pain management drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Anesthetics; Anticonvulsants; Anti-Migraine Agents; Antidepressants; Opioids; Nonnarcotic Analgesics
2) By Indication: Arthritic Pain; Neuropathic Pain; Cancer Pain; Chronic Back Pain; Postoperative Pain; Migraine; Fibromyalgia; Muscle Sprain Or Strain; Bone Fracture; Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Biotechnology, Genomics & Precision Medicine
4.1.3 Industry 4.0 & Intelligent Manufacturing
4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Personalized Pain Management Therapies
4.2.2 Telemedicine & Remote Pain Monitoring
4.2.3 Novel Analgesic Drug Formulations
4.2.4 Minimally Invasive Pain Relief Techniques
4.2.5 Combination Therapy Approaches
5. Pain Management Drugs Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Pain Clinics
5.3 Ambulatory Surgical Centers
5.4 Home Healthcare Providers
5.5 Rehabilitation Centers
6. Pain Management Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Pain Management Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Pain Management Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Pain Management Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Pain Management Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Pain Management Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Pain Management Drugs Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Pain Management Drugs Market Segmentation
9.1. Global Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.2. Global Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain Or Strain, Bone Fracture, Other Indications
9.3. Global Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Pain Management Drugs Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Local Anesthetics, General Anesthetics
9.6. Global Pain Management Drugs Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gabapentin, Pregabalin, Carbamazepine, Topiramate
9.7. Global Pain Management Drugs Market, Sub-Segmentation Of Anti-Migraine Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Triptans, Ergot Alkaloids, CGRP Inhibitors
9.8. Global Pain Management Drugs Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tricyclic Antidepressants, SNRIs
9.9. Global Pain Management Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Morphine, Oxycodone, Hydrocodone, Fentanyl
9.10. Global Pain Management Drugs Market, Sub-Segmentation Of Nonnarcotic Analgesics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Acetaminophen, Aspirin, Other Analgesics
10. Pain Management Drugs Market Regional And Country Analysis
10.1. Global Pain Management Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Pain Management Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Pain Management Drugs Market
12.1. China Pain Management Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Pain Management Drugs Market
13.1. India Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Pain Management Drugs Market
14.1. Japan Pain Management Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Pain Management Drugs Market
15.1. Australia Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Pain Management Drugs Market
16.1. Indonesia Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Pain Management Drugs Market
17.1. South Korea Pain Management Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Pain Management Drugs Market
19.1. South East Asia Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Pain Management Drugs Market
20.1. Western Europe Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Pain Management Drugs Market
21.1. UK Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Pain Management Drugs Market
22.1. Germany Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Pain Management Drugs Market
23.1. France Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Pain Management Drugs Market
24.1. Italy Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Pain Management Drugs Market
25.1. Spain Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Pain Management Drugs Market
26.1. Eastern Europe Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Pain Management Drugs Market
27.1. Russia Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Pain Management Drugs Market
28.1. North America Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Pain Management Drugs Market
29.1. USA Pain Management Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Pain Management Drugs Market
31.1. South America Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Pain Management Drugs Market
32.1. Brazil Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Pain Management Drugs Market
33.1. Middle East Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Pain Management Drugs Market
34.1. Africa Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Pain Management Drugs Market, Segmentation By Drug Class, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Pain Management Drugs Market Regulatory and Investment Landscape
36. Pain Management Drugs Market Competitive Landscape And Company Profiles
